Bioorganic & Medicinal Chemistry Letters 2009-06-15

Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.

James McNulty, Jerald J Nair, Mohini Singh, Denis J Crankshaw, Alison C Holloway, Jaume Bastida

Index: Bioorg. Med. Chem. Lett. 19 , 3233-7, (2009)

Full Text: HTML

Abstract

A library of natural and semi-synthetic Amaryllidaceae alkaloids was screened for cytochrome P450 3A4 (CYP3A4) inhibitory activity. Of the crinane, lycorane and galanthamine representatives examined two semi-synthetic silylated lycorane analogues, accessed via a chemoselective silylation strategy from lycorine, and the natural compound narciclasine exhibited low micromolar activities. Important pharmacological features uncovered include the lack of CYP3A4 inhibitory activity seen for galanthamine and the selective activity that is seen with narciclasine over pancratistatin.


Related Compounds

Related Articles:

Diclofenac toxicity in human intestine ex vivo is not related to the formation of intestinal metabolites.

2015-01-01

[Arch. Toxicol. 89(1) , 107-19, (2015)]

Neuropharmacokinetics of two investigational compounds in rats: divergent temporal profiles in the brain and cerebrospinal fluid.

2014-10-15

[Biochem. Pharmacol. 91(4) , 543-51, (2014)]

Activation of the pleiotropic drug resistance pathway can promote mitochondrial DNA retention by fusion-defective mitochondria in Saccharomyces cerevisiae.

2014-07-01

[G3 (Bethesda) 4(7) , 1247-58, (2014)]

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

2010-01-01

[Chem. Res. Toxicol. 23 , 171-83, (2010)]

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

More Articles...